ASTRAL
Back to catalog
GLP-3 Astral research vial

GLP-3

39-aa GIP / GLP-1 / Glyc triagonist

A 39-amino-acid synthetic triple agonist with binding affinity at the GIP, GLP-1 and Glyc receptors. Supplied as a reference compound for in-vitro receptor-pharmacology and metabolic-signaling research.

Mass

  • 10 mg$67.99In stock
  • 20 mg$117.99In stock
  • 30 mg$173.99Out of stock

From $67.99Purity 99.09%Third-party tested— View COA

View purchase options

Specifications

GLP-3 — Specifications
CAS number2381089-83-2
Molecular weight4731.4 g/mol
FormLyophilized powder
Purity (latest released COA)99.09% · AST-RT10-001
Net quantity10 mg / vial

Handling & storage

GLP-3 — Handling & storage
GuidanceStore lyophilized powder at −20 °C, protected from light. After reconstitution with bacteriostatic water, store at 2–8 °C and use within 30 days. Every vial ships with a batch-specific Certificate of Analysis.
For laboratory research use only. Not a drug, food, cosmetic or supplement. Not for human or veterinary consumption, diagnosis, or treatment.

Documentation

Certificates of Analysis

Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.

Current released record

AST-RT30-001

Dosage
30 mg
Purity
99.751%
Laboratory
Janoshik Analytical
Analyzed
2026-08-05
Open source PDF

Current released record

AST-RT20-001

Dosage
20 mg
Purity
99.61%
Laboratory
Janoshik
Analyzed
2026-05-11
Open source PDF

Current released record

AST-RT10-001

Dosage
10 mg
Purity
99.09%
Laboratory
ILS Laboratories
Analyzed
2026-08-06
Open source PDF

View the compound COA record →